Genetics and diagnosis of central diabetes insipidus

Annales d'Endocrinologie

Volumn 73, Issue 2, 2012, Pages 117-127

  Bichet, Daniel G ^a  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; LITHIUM; NEUROPHYSIN; OXYTOCIN; SATAVAPTAN; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 2 ANTAGONIST; VANILLOID RECEPTOR 4; VANILLOID RECEPTOR ANTAGONIST;

ARTICLE; AUTOSOMAL DOMINANT NEUROHYPOPHYSEAL DIABETES INSIPIDUS; AUTOSOMAL RECESSIVE NEUROHYPOPHYSEAL DIABETES INSIPIDUS; AVP GENE; BLOOD ANALYSIS; DELIVERY; DIABETES INSIPIDUS; DISEASE ASSOCIATION; ENDOPLASMIC RETICULUM; FAMILIAL NEUROHYPOPHYSEAL DIABETES INSIPIDUS; FEEDING DISORDER; GENE; GENE MUTATION; GENE SEQUENCE; GESTATIONAL AGE; HORMONAL REGULATION; HORMONE SYNTHESIS; HUMAN; HYPERNATREMIA; HYPEROSMOTIC STRESS; HYPODIPSIA; IMMUNOCYTOCHEMISTRY; KIDNEY CONCENTRATING CAPACITY; NOCTURIA; NOCTURNAL POLYURIA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; OSMOREGULATION; OXT GENE; PATIENT CARE; POLYDIPSIA; POLYURIA; PREGNANCY; PROTEIN EXPRESSION; RADIOIMMUNOLOGY; RARE DISEASE; SODIUM BLOOD LEVEL; TRANSSPHENOIDAL SURGERY; URINALYSIS; URINE OSMOLALITY; VASOPRESSIN RELEASE;

ANIMALS; ARGININE VASOPRESSIN; DIABETES INSIPIDUS; DIABETES INSIPIDUS, NEUROGENIC; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MICE; MICE, KNOCKOUT; PREGNANCY; PREGNANCY IN DIABETICS;

EID: 84860919989     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2012.03.030     Document Type: Article

References (100)

1. Bourque C.W. Central mechanisms of osmosensation and systemic osmoregulation. Nat Rev Neurosci 2008, 9:519-531.
2. Lechner S.G., Markworth S., Poole K., Smith E.S., Lapatsina L., Frahm S., et al. The molecular and cellular identity of peripheral osmoreceptors. Neuron 2011, 69:332-344.
3. Burbach J.P., Luckman S.M., Murphy D., Gainer H. Gene regulation in the magnocellular hypothalamo-neurohypophysial system. Physiol Rev 2001, 81:1197-1267.
4. Rao V.V., Loffler C., Battey J., Hansmann I. The human gene for oxytocin-neurophysin I (OXT) is physically mapped to chromosome 20p13 by in situ hybridization. Cell Genet 1992, 61:271-273.
5. Sausville E., Carney D., Battey J. The human vasopressin gene is linked to the oxytocin gene and is selectively expressed in a cultured lung cancer cell line. J Biol Chem 1985, 260:10236-10241.
6. Venkatesh B., Si-Hoe S.L., Murphy D., Brenner S. Transgenic rats reveal functional conservation of regulatory controls between the Fugu isotocin and rat oxytocin genes. Proc Natl Acad Sci USA 1997, 94:12462-12466.
7. Chen L., Rose J.P., Breslow E., Yang D., Chang W.R., Furey W.F.J., et al. Crystal structure of a bovine neurophysin II dipeptide complex at 2.8 Angström determined from the single-wave length anomalous scattering signal of an incorporated iodine atom. Proc Natl Acad Sci USA 1991, 88:4240-4244.
8. Vandesande F., Dierickx K. Identification of the vasopressin producing and of the oxytocin producing neurons in the hypothalamic magnocellular neurosecretroy system of the rat. Cell Tissue Res 1975, 164:153-162.
9. Swab D., Pool W.C., Novelty F. Immunofluorescence of vasopressin and oxytocin in the rat hypothalamo-neurohypophyseal system. J Neural Transmis 1975, 36:195.
10. Sofroniew M. Morphology of vasopressin and oxytocin neurones and their central and vascular projections 1883, Elsevier, New York, Vol. 60.
11. Yanovski J.A., Friedman T.C., Nieman L.K., Chrousos G.P., Cutler G.B., Doppman J.L., et al. Inferior petrosal sinus AVP in patients with Cushing's syndrome. Clin Endocrinol (Oxf) 1997, 47:199-206.
12. Kalogeras K.T., Nieman L.N., Friedman T.C., Doppman J.L., Cutler G.B.J., Chrousos G.P., et al. Inferior petrosal sinus sampling in healthy human subjects reveals a unilateral corticotropin-releasing hormone-induced arginine vasopressin release associated with ipsilateral adrenocorticotropin secretion. J Clin Invest 1996, 97:2045-2050.
13. Edwards A.M., Mann M.E., Marfell-Jones M.J., Rankin D.M., Noakes T.D., Shillington D.P. Influence of moderate dehydration on soccer performance: physiological responses to 45min of outdoor match-play and the immediate subsequent performance of sport-specific and mental concentration tests. Br J Sports Med 2007, 41:385-391.
14. Saat M., Sirisinghe R.G., Singh R., Tochihara Y. Effects of short-term exercise in the heat on thermoregulation, blood parameters, sweat secretion and sweat composition of tropic-dwelling subjects. J Physiol Anthropol Appl Human Sci 2005, 24:541-549.
15. Shirreffs S.M, Merson S.J., Fraser S.M., Archer D.T. The effects of fluid restriction on hydration status and subjective feelings in man. Br J Nutr 2004, 91:951-958.
16. Geelen G., Greenleaf J.E., Keil L.C. Drinking-induced plasma vasopressin and norepinephrine changes in dehydrated humans. J Clin Endocrinol Metab 1996, 81:2131-2135.
17. Andersen L.J., Jensen T.U., Bestle M.H., Bie P. Gastrointestinal osmoreceptors and renal sodium excretion in humans. Am J Physiol Regul Integr Comp Physiol 2000, 278:R287-R294.
18. Claybaugh J.R., Sato A.K., Crosswhite L.K., Hassell L.H. Effects of time of day, gender, and menstrual cycle phase on the human response to a water load. Am J Physiol Regul Integr Comp Physiol 2000, 279:R966-R973.
19. Verney E. The antidiuretic hormone and the factors which determine its release. Proc R Soc London Ser B 1947, 135:25-26.
20. Ramsay D.J., Thrasher T.N., Keil L.C. The organum vasculosum laminae terminalis: a critical area for osmoreception. Prog Brain Res 1983, 60:91-98.
21. Ciura S., Bourque C.W. Transient receptor potential vanilloid 1 is required for intrinsic osmoreception in organum vasculosum lamina terminalis neurons and for normal thirst responses to systemic hyperosmolality. J Neurosci 2006, 26:9069-9075.
22. Denton D.A., McKinley M.J., Weisinger R.S. Hypothalamic integration of body fluid regulation. Proc Natl Acad Sci USA 1996, 93:7397-7404.
23. McKinley M.J., Denton D.A., Oldfield B.J., De Oliveira L.B., Mathai M.L. Water intake and the neural correlates of the consciousness of thirst. Semin Nephrol 2006, 26:249-257.
24. Johnson A.K. The sensory psychobiology of thirst and salt appetite. Med Sci Sports Exerc 2007, 39:1388-1400.
25. Hollis J.H., McKinley M.J., D'Souza M., Kampe J., Oldfield B.J. The trajectory of sensory pathways from the lamina terminalis to the insular and cingulate cortex: a neuroanatomical framework for the generation of thirst. Am J Physiol Regul Integr Comp Physiol 2008, 294:R1390-R1401.
26. Ciura S., Liedtke W., Bourque C.W. Hypertonicity sensing in organum vasculosum lamina terminalis neurons: a mechanical process involving TRPV1 but not TRPV4. J Neurosci 2011, 31:14669-14676.
27. Zhang Z., Bourque C.W. Amplification of transducer gain by angiotensin II-mediated enhancement of cortical actin density in osmosensory neurons. J Neurosci 2008, 28:9536-9544.
28. Robertson G.L., Athar S. The interaction of blood osmolality and blood volume in regulating plasma vasopressin in man. J Clin Endocrinol Metab 1976, 42:613-620.
29. Sharif Naeini R., Witty M.F., Seguela P., Bourque C.W. An N-terminal variant of Trpv1 channel is required for osmosensory transduction. Nat Neurosci 2006, 9:93-98.
30. Taylor A.C., McCarthy J.J., Stocker S.D. Mice lacking the transient receptor vanilloid potential 1 channel display normal thirst responses and central Fos activation to hypernatremia. Am J Physiol Regul Integr Comp Physiol 2008, 294:R1285-R1293.
31. McHugh J., Keller N.R., Appalsamy M., Thomas S.A., Raj S.R., Diedrich A., et al. Portal osmopressor mechanism linked to transient receptor potential vanilloid 4 and blood pressure control. Hypertension 2010, 55:1438-1443.
32. Boschmann M., Steiniger J., Franke G., Birkenfeld A.L., Luft F.C., Jordan J. Water drinking induces thermogenesis through osmosensitive mechanisms. J Clin Endocrinol Metab 2007, 92:3334-3337.
33. Tank J., Schroeder C., Stoffels M., Diedrich A., Sharma A.M., Luft F.C., Jordan J. Pressor effect of water drinking in tetraplegic patients may be a spinal reflex. Hypertension 2003, 41:1234-1239.
34. Jordan J., Shannon J.R., Black B.K., Ali Y., Farley M., Costa F., et al. The pressor response to water drinking in humans: a sympathetic reflex?. Circulation 2000, 101:504-509.
35. Schroeder C., Bush V.E., Norcliffe L.J., Luft F.C., Tank J., Jordan J., et al. Water drinking acutely improves orthostatic tolerance in healthy subjects. Circulation 2002, 106:2806-2811.
36. Shannon J.R., Diedrich A., Biaggioni I., Tank J., Robertson R.M., Robertson D., et al. Water drinking as a treatment for orthostatic syndromes. Am J Med 2002, 112:355-360.
37. Claydon V.E., Schroeder C., Norcliffe L.J., Jordan J., Hainsworth R. Water drinking improves orthostatic tolerance in patients with posturally related syncope. Clin Sci (Lond) 2006, 110:343-352.
38. Stookey J.D., Constant F., Popkin B.M., Gardner C.D. Drinking water is associated with weight loss in overweight dieting women independent of diet and activity. Obesity (Silver Spring) 2008, 16:2481-2488.
39. Coste B., Mathur J., Schmidt M., Earley T.J., Ranade S., Petrus M.J., et al. Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels. Science 2010, 330:55-60.
40. Valtin H., North W.G., Edwards B.R., Gellai M. Animal models of diabetes insipidus. Frontiers Hormone Res 1985, 13:105-126.
41. Schmale H., Richter D. Single base deletion in the vasopressin gene is the cause of diabetes insipidus in Brattleboro rats. Nature 1984, 308:705-709.
42. Schmale H., Bahnsen U., Fehr S., Nahke D., Richter D. Hereditary diabetes insipidus in man and rat 1991, John Libbey Eurotext, Paris.
43. Richter D. Reflections on central diabetes insipidus: retrospective and perspectives. Vasopressin 1993, John Libbey Eurotext, Paris, p. 3-14. P. Gross, D. Richter, G.L. Robertson (Eds.).
44. Serradeil-Le Gal C., Lacour C., Valette G., Garcia G., Foulon L., Galindo G., et al. Characterization of SR 121463A: a highly potent and selective, orally active vasopressin V2 receptor antagonist. J Clin Invest 1996, 98:2729-2738.
45. Jean-Alphonse F., Perkovska S., Frantz M.C., Durroux T., Mejean C., Morin D., et al. Biased agonist pharmacochaperones of the AVP V2 receptor may treat congenital nephrogenic diabetes insipidus. J Am Soc Nephrol 2009, 20:2190-2203.
46. Evans D.A., De Bree F.M., Nijenhuis M., Van Der Kleij A.A., Zalm R., Korteweg N., et al. Processing of frameshifted vasopressin precursors. J Neuroendocrinol 2000, 12:685-693.
47. Chou C.L., DiGiovanni S.R., Luther A., Lolait S.J., Knepper M.A. Oxytocin as an antidiuretic hormone II. Role of V2 vasopressin receptor. Am J Physiol (Renal Fluid Electrolyte Physiol. 38) 1995, 269:F78-F85.
48. Balment R.J., Brimble M.J., Forsling M.L. Oxytocin release and renal actions in normal and Brattleboro rats. Ann N Y Acad Sci US 1982, 394:241-253.
49. Postoperative and post-traumatic diabetes insipidus 1985, S. Karger, Basel. Vol. 13. J.G. Verbalis, A.G. Robinson, A.M. Moses (Eds.).
50. Olson B.R., Gumowski J., Rubino D., Oldfield E.H. Pathophysiology of hyponatremia after transsphenoidal pituitary surgery. J Neurosurg 1997, 87:499-507.
51. Maghnie M., Cosi G., Genovese E., Manca-Bitti M.L., Cohen A., Zecca S., et al. Central diabetes insipidus in children and young adults. N Engl J Med 2000, 343:998-1007.
52. Greger N.G., Kirkland R.T., Clayton G.W., Kirkland J.L. Central diabetes insipidus. 22 years' experience. Am J Dis Child 1986, 140:551-554.
53. Neurogenic Diabetes insipidus in children 1985, S. Karger, Basel. Vol. 13. P. Czernichow, R. Pomarede, R. Brauner (Eds.).
54. Acid-base and electrolyte disorders associated with endocrine disease: pituitary and thyroid 1985, Churchill Livingstone, New York. A.M. Moses, S.A. Blumenthal, D.H. Streeten (Eds.).
55. Birnbaum D.C., Shields D., Lippe B., Perlman S., Phillipart M. Idiopathic central diabetes insipidus followed by progressive spastic cerebral ataxia. Report of four cases. Arch Neurol 1989, 46:1001-1003.
56. Bullmann C., Faust M., Hoffmann A., Heppner C., Jockenhovel F., Muller-Wieland D., et al. Five cases with central diabetes insipidus and hypogonadism as first presentation of neurosarcoidosis. Eur J Endocrinol 2000, 142:365-372.
57. Vokes T.J., Gaskill M.B., Robertson G.L. Antibodies to vasopressin in patients with diabetes insipidus. Implications for diagnosis and therapy. Ann Intern Med 1988, 108:190-195.
58. Bichet D.G., Kortas C., Manzini C., Barjon J.N. A specific antibody to vasopressin in a man with concomitant resistance to treatment with Pitressin. Clin Chem 1986, 32:211-212.
59. Kaltsas G.A., Powles T.B., Evanson J., Plowman P.N., Drinkwater J.E., Jenkins P.J., et al. Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. J Clin Endocrinol Metab 2000, 85:1370-1376.
60. McKusick VA. Online Mendelian Inheritance in Man OMIM, (TM). McKusick-Nathans Institute for Genetic Medicine, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD), 2000. World Wide Web URL: . http://www.ncbi.nlm.nih.gov/omim/.
61. Lacombe U.L. De la polydipsie, p 87 1841, Imprimerie et Fonderie de Rignoux, Paris.
62. Weil A. Ueber die hereditare form des diabetes insipidus. Archives fur Pathologische Anatomie und Physiologie and fur Klinische Medicine (Virchow's Archives) 1884, 95:70-95.
63. Weil A. Ueber die hereditare form des diabetes insipidus. Deutches Archiv fur Klinische Medizin 1908, 93:180-290.
64. Camerer J.W. Eine ergänzung des Weilschen diabetes-insipidus-stammbaumes. Archiv für Rassen-und Gesellschaftshygiene Biologie 1935, 28:382-385.
65. Dölle W. Eine weitere ergänzung des Weilschen diabetes-insipidus-stammbaumes. Zeitschrift für Menschliche Vererbungs-und Konstitutionslehre 1951, 30:372-374.
66. Rittig S., Siggaard C., Ozata M., Yetkin I., Gundogan M.A., Robertson G.L., et al. Familial neurohypophyseal diabetes insipidus due to mutation that substitutes histidine for tyrosine-2 in the antidiuretic hormone. J Invest Med 1996, 44:387A.
67. Brachet C., Birk J., Christophe C., Tenoutasse S., Velkeniers B., Heinrichs C., et al. Growth retardation in untreated autosomal dominant familial neurohypophyseal diabetes insipidus caused by one recurring and two novel mutations in the vasopressin-neurophysin II gene. Eur J Endocrinol 2011, 164:179-187.
68. Birk J., Friberg M.A., Prescianotto-Baschong C., Spiess M., Rutishauser J. Dominant pro-vasopressin mutants that cause diabetes insipidus form disulfide-linked fibrillar aggregates in the endoplasmic reticulum. J Cell Sci 2009, 122:3994-4002.
69. Castino R., Davies J., Beaucourt S., Isidoro C., Murphy D. Autophagy is a prosurvival mechanism in cells expressing an autosomal dominant familial neurohypophyseal diabetes insipidus mutant vasopressin transgene. FASEB J 2005, 19:1021-1023.
70. Abu Libdeh A., Levy-Khademi F., Abdulhadi-Atwan M., Bosin E., Korner M., White P.C., et al. Autosomal recessive familial neurohypophyseal diabetes insipidus: onset in early infancy. Eur J Endocrinol 2009, 162:221-226.
71. Willcutts M.D., Felner E., White P.C. Autosomal recessive familial neurohypophyseal diabetes insipidus with continued secretion of mutant weakly active vasopressin. Hum Mol Genet 1999, 8:1303-1307.
72. Christensen JH, Kvistgaaard H, Knudsen J, Shaikh G, Tolmie J, Cooke S, et al. A novel deletion partly removing the Avp gene causes autosomal recessive inheritance of early onset neurohypophyseal diabetes insipidus, Clin Genet 2012, . doi:10.1111/j.1399-0004.2011.01833.x.
73. Bichet D.G., Arthus M.-F., Lonergan M., Morgan K., Fujiwara T.M. Hereditary central diabetes insipidus: autosomal dominant and autosomal recessive phenotypes due to mutations in the prepro-AVP-NPII gene. J Am Soc Nephrol 1998, 9:386A.
74. Christensen J.H., Siggaard C., Corydon T.J., Robertson G.L., Gregersen N., Bolund L., et al. Differential cellular handling of defective arginine vasopressin (AVP) prohormones in cells expressing mutations of the AVP gene associated with autosomal dominant and recessive familial neurohypophyseal diabetes insipidus. J Clin Endocrinol Metab 2004, 89:4521-4531.
75. Beuret N., Stettler H., Renold A., Rutishauser J., Spiess M. Expression of regulated secretory proteins is sufficient to generate granule-like structures in constitutively secreting cells. J Biol Chem 2004, 279:20242-20249.
76. Takeda K., Inoue H., Tanizawa Y., Matsuzaki Y., Oba J., Watanabe Y., et al. WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain. Hum Mol Genet 2001, 10:477-484.
77. Domenech E., Gomez-Zaera M., Nunes V. Study of the WFS1 gene and mitochondrial DNA in Spanish Wolfram syndrome families. Clin Genet 2004, 65:463-469.
78. Ishihara H., Takeda S., Tamura A., Takahashi R., Yamaguchi S., Takei D., et al. Disruption of the WFS1 gene in mice causes progressive beta-cell loss and impaired stimulus-secretion coupling in insulin secretion. Hum Mol Genet 2004, 13:1159-1170.
79. Conlan A.R., Axelrod H.L., Cohen A.E., Abresch E.C., Zuris J., Yee D., et al. Crystal structure of Miner1: The redox-active 2Fe-2S protein causative in Wolfram Syndrome 2. J Mol Biol 2009, 392:143-153.
80. Fonseca S.G., Ishigaki S., Oslowski C.M., Lu S., Lipson K.L., Ghosh R., et al. Wolfram syndrome 1 gene negatively regulates ER stress signaling in rodent and human cells. J Clin Invest 2010, 120:744-755.
81. Crowley R.K., Sherlock M., Agha A., Smith D., Thompson C.J. Clinical insights into adipsic diabetes insipidus: a large case series. Clin Endocrinol (Oxf) 2007, 66:475-482.
82. Howard R.L., Bichet D.G., Schrier R.W. Hypernatremic and polyuric states. The Kidney: physiology and pathophysiology 1992, Raven Press, Ltd, New York, p. 1753-78. 2nd ed. D.W. Seldin, G. Giebisch (Eds.).
83. Amico J.A. Diabetes insipidus and pregnancy. Frontiers of Hormone Research 1985, Karger, Basel, p. 266-77. P.A.G.R. Czernichow (Ed.).
84. Davison J.M., Shiells E.A., Philips P.R., Lindheimer M.D. Suppression of AVP release by drinking despite hypertonicity during and after gestation. Am J Physiol 1988, 254:F588-F592.
85. Iwasaki Y., Oiso Y., Kondo K., Takagi S., Takatsuki K., Hasegawa H., et al. Aggravation of subclinical diabetes insipidus during pregnancy. N Engl J Med 1991, 324:522-526.
86. Forssman J. On hereditary diabetes insipidus, with special regard to a sex-linked form. Acta Med Scand 1945, 159:1-196.
87. Barron W.M, Cohen L.H., Ulland L.A., Lassiter W.E., Fulghum E.M., Emmanouel D., et al. Transient vasopressin-resistant diabetes insipidus of pregnancy. N Engl J Med 1984, 310:442-444.
88. Durr J.A., Hoggard J.G., Hunt J.M., Schrier R.W. Diabetes insipidus in pregnancy associated with abnormally high circulating vasopressinase activity. N Engl J Med 1987, 316:1070-1074.
89. Lindheimer M.D. Polyuria and pregnancy: its cause, its danger. Obstet Gynecol 2005, 105:1171-1172.
90. Hiett A.K, Barton J.R. Diabetes insipidus associated with craniopharyngioma in pregnancy. Obstet Gynecol 1990, 76:982-984.
91. Brewster U.C., Hayslett J.P. Diabetes insipidus in the third trimester of pregnancy. Obstet Gynecol 2005, 105:1173-1176.
92. Trudel E., Bourque C.W. Central clock excites vasopressin neurons by waking osmosensory afferents during late sleep. Nat Neurosci 2010, 13:467-474.
93. Barlow E.D., de Wardener H.E. Compulsive water drinking. Q J Med New Series 1959, 28:235-258.
94. Denton K.M. In the arms of Morpheus. Am J Physiol Renal Physiol 2012, 302(2):234-235. [Epub 2011 Nov 9]. 10.1152/ajprenal.00602.2011.
95. Mahler B.T., Kamperis K., Schroeder M., Frokiaer J., Djurhuus J.C., Rittig S. Sleep deprivation induces excess diuresis and natriuresis in healthy children. Am J Physiol Renal Physiol 2011.
96. Leaf A. Nephrology forum: neurogenic diabetes insipidus. Kidney Int 1979, 15:572-580.
97. Babey M., Kopp P., Robertson G.L. Familial forms of diabetes insipidus: clinical and molecular characteristics. Nat Rev Endocrinol 2011, 7:701-714.
98. Bichet DG. Clinical manifestations and causes of nephrogenic diabetes insipidus. UpToDate, , 2011. http://www.uptodate.com/.
99. Robertson G.L. Diseases of the posterior pituitary. Endocrinology and Metabolism 1981, McGraw-Hill, New York, p. 251. D. Felig, J.D. Baxter, A.E. Broadus (Eds.).
100. Bichet D.G. The Posterior Pituitary. The Pituitary 2011, Elsevier, London, p. 261-99. S. Melmed (Ed.).